Intermittent androgen suppression in the management of prostate cancer
- 1 March 1999
- Vol. 53 (3) , 530-534
- https://doi.org/10.1016/s0090-4295(98)00547-0
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Loss of androgen dependence is associated with an increase in tumorigenic stem cells and resistance to cell-death genesPublished by Elsevier ,2003
- Long-Term Efficacy and Safety of Nilutamide Plus Castration in Advanced Prostate Cancer, and the Significance of Early Prostate Specific Antigen NormalizationJournal of Urology, 1997
- Immediate versus deferred treatment for advanced prostatic cancer: initial results of the Medical Research Council trialBritish Journal of Urology, 1997
- Intermittent androgen suppression with leuprolide and flutamide for prostate cancer: A pilot studyUrology, 1996
- Maximum androgen blockade in advanced prostate cancer: an overview of 22 randomised trials with 3283 deaths in 5710 patientsThe Lancet, 1995
- Intermittent androgen suppression in the treatment of prostate cancer: A preliminary reportUrology, 1995
- Treatment of Clinical Local Failure after Radiation Therapy for Prostate CarcinomaJournal of Urology, 1993
- A Controlled Trial of Leuprolide with and without Flutamide in Prostatic CarcinomaNew England Journal of Medicine, 1989
- Successive waves of apoptosis in the rat prostate after repeated withdrawal of testosterone stimulationPathology, 1984
- New approach in the treatment of prostate cancer: Complete instead of partial withdrawal of androgensThe Prostate, 1983